Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

N/A
2(100.0%)
2Total
N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT06854016Not ApplicableRecruiting

Performance and Safety of LightForce® Therapy Lasers on Lateral Ankle Sprain

Role: collaborator

NCT06654739Not ApplicableActive Not Recruiting

RCT on the Performance and Safety of LightForce® Therapy Lasers on Knee Osteoarthritis Pain Reduction (SPARK)

Role: collaborator

NCT06809283Recruiting

Observational Prospective PMCF Study to Confirm Performance and Safety of Intelect® Devices in Real World

Role: collaborator

NCT06049732Completed

PainChek® US Validation Nursing Home Study

Role: collaborator

All 4 trials loaded